AU2003238999B2 - System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding - Google Patents

System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding Download PDF

Info

Publication number
AU2003238999B2
AU2003238999B2 AU2003238999A AU2003238999A AU2003238999B2 AU 2003238999 B2 AU2003238999 B2 AU 2003238999B2 AU 2003238999 A AU2003238999 A AU 2003238999A AU 2003238999 A AU2003238999 A AU 2003238999A AU 2003238999 B2 AU2003238999 B2 AU 2003238999B2
Authority
AU
Australia
Prior art keywords
phosphate
powdered material
hydration liquid
bonding
apatite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003238999A
Other versions
AU2003238999A1 (en
Inventor
Nils-Otto Ahnfelt
Hakan Engqvist
Leif Hermansson
Lars Kraft
Jesper Loof
Jan-Erik Schulz-Walz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Doxa AB
Original Assignee
Doxa AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0201920A external-priority patent/SE522511C2/en
Priority claimed from SE0201921A external-priority patent/SE522510C2/en
Priority claimed from SE0202998A external-priority patent/SE0202998D0/en
Application filed by Doxa AB filed Critical Doxa AB
Publication of AU2003238999A1 publication Critical patent/AU2003238999A1/en
Application granted granted Critical
Publication of AU2003238999B2 publication Critical patent/AU2003238999B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B28/00Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
    • C04B28/34Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838Phosphorus compounds, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • A61K6/853Silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • A61K6/864Phosphate cements
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00474Uses not provided for elsewhere in C04B2111/00
    • C04B2111/00836Uses not provided for elsewhere in C04B2111/00 for medical or dental applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ceramic Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Prostheses (AREA)

Description

P OPERNJL\L2546710 amendoc-26/03/2009 SYSTEM FOR A DENTAL FILLING MATERIAL OR IMPLANT MATERIAL, AND POWDERED MATERIAL, HYDRATION LIQUID, IMPLANT MATERIAL AND METHOD OF ACHIEVING BONDING 5 TECHNICAL FIELD The present invention relates to a system for a dental filling material or an implant material, alternatively a system for bonding between a tooth or a bone and a dental filling material and a implant material, respectively. The invention also relates to the powdered material and the hydration liquid as such, and also an implant material comprising the 10 system and a method of achieving bonding using the system. In the following, the terms "system", "cement system", "binding agent system" and "binder system" and similar relate to both embodiments of the invention mentioned above, i.e. the system for a dental filling material or implant material and the system for bonding between 15 a tooth or a bone and a dental filling material and an implant material, respectively, if nothing else is said. The term "implant" or "implant material" and similar, also comprise orthopaedic bone void fillers. 20 PRIOR ART Herein described is a binding agent system of the hydrating cement system type, in particular calcium aluminate cement-based systems that comprise chemically bonded ceramics. The implant of the invention can be used for biomaterials for dental and 25 orthopaedic applications, such as implants including fillers and coatings and bonding systems. For materials, such as dental filling materials and implants, that are to interact with the human body, it is an advantage that the materials are made as bioactive or biocompatible 30 as possible. As to ceramic materials, it can be said that apatite is the body's own ceramic, why apatite from this point of view ought to be excellent as a dental filling material or P:OPER\NIL%12546710 amaxdoc-26/3/2009 -2 implant. Apatite materials as such however generally don't exhibit the other properties that are required for dental filling materials and implants, such as good handling ability with simple applicability in a cavity, moulding that permits good modellability, hardening/solidification that is sufficiently rapid for filling work and provides 5 serviceability directly following a visit to the dentist, high hardness, corrosion resistance, good aesthetics and good long time properties in terms of dimensional stability. For the purpose of providing a material that fulfils at least most of these required properties, a material has been developed according to what is presented in SE 463,493, SE 502,987, WO 00/21489, WO 01/76534 and WO 01/76535, e.g. It is also suggested in SE 463,493 10 and SE 502,987 that such materials may comprise an apatite ballast. When a dental filling/implant material is applied against tooth or a bone, it is furthermore of utmost importance that a good bonding is achieved between the material and the tooth/bone. Known dental filling materials according to the patent applications mentioned 15 above will certainly give an acceptable bonding, but there is free scope for improvements. ACCOUNT OF THE INVENTION According to a first aspect of the invention there is provided a system for a dental filling material or an implant material, alternatively a system for bonding between a tooth or a 20 bone and a dental filling material and a implant material respectively, which system comprises a water based hydration liquid and a powdered material, the powdered material comprising a binder phase consisting essentially of a calcium aluminate based cement system, the powdered material having the capacity following saturation with the hydration liquid of reacting to form a chemically bonded ceramic material, wherein said powdered 25 material and/or said hydration liquid comprises water soluble phosphate or a phase that has the capacity to form water soluble phosphate so that apatite is formed during and/or after hydration of said powdered material. Preferably, the system has the capacity to form 0.01 to 30 % by volume apatite during and/or after hydration, preferably 0.01 to 60%. The system comprises the components that are necessary for the formation of apatite, e.g. 30 hydroxyapatite or fluoride-apatite ((Ca 5
(PO
4
)
3 0H and Ca 5
(PO
4
)
3 F, respectively) and optionally some other biologically favourable phase, and the system allows for such phases P \OPER\NIL\l 2546710 amend doc-26/03/2009 -3 to be formed during and/or after the hydration reaction. Hereby, the advantage is at least attained that apatite need not be added as a separate additive. The material formed can be said to constitute a chemically bonded ceramic composite that exhibits many advantages as a dental filling material, as implant material (comprising fillers) or as a coating layer on an 5 implant material, or as a bonding material. The formation of apatite in the material is a sign of the material being bioactive and co-operating with the body. Furthermore, the distribution of apatite will be homogeneous in the material, also in contact zones against biological material, bone and tooth tissue. The formation of apatite in such contact zones is especially favourable for the binding or the bonding alternatively. Another advantage for 10 the formation of apatite is that the environment is basic. Since apatite is, an endogenous substance, the binder system will result in excellent binding properties with a very tight union between the dental filling/implant material and the tooth/bone. The integration with the surroundings having a content of apatite is very important, especially for dental filling materials, orthopaedic pastes and materials lying as a coating on implants. The latter 15 relates to in-situ prepared surface coatings of a chemically bonded ceramic composite based on apatite, having a great influence on bone integration. Surprisingly, it has now been found that a calcium aluminate based cement system comprising phosphate, at a boundary or a gap between a tooth or a bone and a dental filling 20 material and an implant material, respectively, not only provides for the formation of a chemically bonded ceramic composite comprising apatite, but also leads to a faster healing of the tooth or the bone. It has now been found that a chemical and biological integration takes place, that leads to an additional surface growth that chemically diminishes the gap between the tooth/bone and the dental filling material/implant material, but that also, due 25 to the presence of apatite, will result in a faster biological sealing of the gap. The healing or growing process of the bone or the tooth is favoured by the supply of calcium and phosphorous from the cement system. Accordingly, calcium is taken from the calcium aluminate based cement system. Below a 30 surface layer of formed apatite, the content of Ca will therefore be somewhat reduced, which leads to an increased formation of gibbsite phase in the produced ceramic material.
P OPER\NJL\12546710 amnod doc-26/03/2009 -4 The extension of this gibbsite phase may be controlled by the content of Ca and the addition of phosphate in the contact zone. Another aspect of the formation of hydroxyapatite (formation of HAP) in connection with 5 the general mechanism at hardening comprising dissolving and depositing, is that the system may act to favour healing at attacks on tooth or bone tissue. Hereby, the biological material that has lost its hard material (its biologically formed apatite) is remineralised by Ca-aluminate with a source of phosphorous reacting with water of body fluid. The material is dissolved, i.e. becomes a solution and ions such as calcium, aluminate, phosphate, 10 hydroxyl and optional additives, such as fluoride, is deposited in all voids, including those coming from previous bone decay. This means that also caries that unintentionally have been left after treatment, can be remineralised. Also other bone materials can be favoured in healing in a corresponding manner, e.g. related to osteoporosis etc. 15 At attacks of caries or other bone decay, the surface may therefore be pre-treated by a cement system that contains a lot of calcium and phosphorous, in order to facilitate a fast and efficient formation of materials containing HAP. One concept is that the hydration liquid contains phosphoric acid with tricalcium phosphate and that the binder phase of the cement essentially consists of fine grain (< 5 pm, preferably < 1 pm grain size) of C 3 A (i.e. 20 3CaO-A 2 0 3 ). According to a second aspect of the invention there is provided a powdered material for use in a system according to the first aspect of the invention, said powdered material comprising a binder phase consisting essentially of a calcium aluminate based cement 25 system, the powdered material having the capacity following saturation with a hydration liquid of reacting to form a chemically bonded ceramic material, wherein the powdered material comprises water soluble phosphate or a phase that has the capacity to form water soluble phosphate so that apatite is formed during and/or after hydration of said powdered material. 30 P:OPER\NIL2546710 smod doc-2&03/2009 -5 According to a third aspect of the invention there is provided an aqueous hydration liquid for use in a system according to the first aspect of the invention, said aqueous hydration liquid for hydrating a powdered material having a binder phase that consists essentially of a calcium aluminate based cement system, said powdered material having the capacity 5 following saturation with the hydration liquid of reacting to hydrate to a chemically bonded ceramic material, wherein the hydration liquid comprises water soluble phosphate or a phase that has the capacity to form water soluble phosphate, so that apatite is formed during and/or after hydration of said powdered material. 10 According to a fourth aspect of the invention there is provided an implant material comprising a substrate, wherein said substrate comprises a hydrated coating layer formed from a system according to the first aspect of the invention. According to a fifth aspect, there is provided a method of achieving bonding between a 15 tooth or a bone and a dental filling material and an implant material respectively, the method comprising using the system for bonding according to the first aspect of the invention. As to the coating of implants, the integration with the bone may be improved and 20 accelerated by: 1. HAP being brought to constitute a part of a coating of CAH-HAP on an implant of metal, ceramics or polymer. The coating being produced and hydrated before implantation. 2. Accelerated/increased formation of HAP after implantation, by an 25 outermost layer having been applied onto the coating by extra addition of non-reacted CA + phosphate. The surface layer may contain a source of phosphorous or the surface may be steeped in a phosphate-containing aqueous solution. Effect: Additional surface growth chemically diminishes the gap, and a 30 faster biological sealing of the gap takes place due to presence of HAP. See also the drawings description.
P OPER\NL 2546710 moaddoc26/03/209 -6 Another way of achieving non-reacted material in the outermost part of the coating, is to: 3. Apply a torque on the coating just before or in connection with the implantation. The surface layer may contain a source of phosphorous or the 5 surface may be steeped in a phosphate-containing aqueous solution. Effect: Releases non-reacted material CAH = the calcium aluminate system CA = calcium aluminate, raw material without water/hydration liquid 10 HAP = hydroxyapatite In the following, an explanation is given considering the effect of the basic system on spontaneous formation of HAP in boundaries between bone tissue and added CA. (Of course, the mechanism also applies generally at presence of phosphate.) At a variation of 15 pH in its surroundings, hydrogen phosphate and dihydrogen phosphate (included in the buffering system of the body) will want to contribute to a neutralisation. A basic system is obtained if CA material is present. The buffering system tries to take care of surplus hydroxyl ions, to form water by a shifting in the buffering system from the dihydrogen phosphate to the hydrogen phosphate or to a phosphate ion (an ion without hydrogen, one 20 hydrogen ion is released and forms water together with a hydroxyl ion). As the equilibrium is shifted towards phosphate, the phosphate content of the solution is increased and apatite = calcium phosphate hydroxide = Cas(PO 4
)
3 (OH) is formed together with Ca-ions and hydroxyl ions. Apatite has a low solubility product, which favours the deposition of the apatite in the surrounding system having a surplus of Ca, hydroxyl ions and the tendency 25 to shift the buffering system towards phosphate. The powdered material The powdered material consists of a calcium aluminate based, basic ceramic powder. The powdered material comprises water soluble phosphate or a phase that has the capacity to 30 form water soluble phosphate, whereby the cement system exhibits the capacity during and/or after hydration to form apatite. Preferably, the phosphate or phosphate-forming POPER\NJL\12546710 am d doc-26t03/2009 -7 phase exists by the cement system comprising phosphate-containing phase in solid solution in the cement system. In addition: 5 a. Said water soluble phosphate may consist of a water soluble, phosphate containing phase, alkali phosphates e.g. For the bonding system especially, the content of phosphate is suitably high, preferably 1-90 %, more preferred 5-60 % and even more preferred 10-30 %. Effect: an increase of the phosphate content in the material will result in an 10 increased content of apatite (not only limited to the phosphate content of the solution). b. The material may comprise grains of phosphate-containing phase, preferably hydroxyapatite and fluoride-apatite, Effect: controlling the precipitation of apatite. 15 c. The material may comprise additives of collagen, elastin or other high molecular proteins that are coated in-situ or are pre-coated by apatite from a saturated solution. Effect: to control the deposition of apatite. d. The material may comprise an additive of a fluoride-containing phase of 20 non difficultly soluble character, fluoride-containing glass (glass ionomer glass) e.g. of non difficultly soluble character, at contents of from 0.5% and up to 10%, preferably below 10 %. Other examples of fluoride-containing phase are calcium fluoride (CaF 2 ) or sodium fluoride (NaF). Effect: a way of introducing fluoride in the material, whereby fluoride 25 apatite can be formed. e. In the bonding system, the binder phase suitably has a larger mole content of calcium that of aluminium, in which case the binder phase preferably comprises or essentially consists of 3CaO-A 2 0 3 (C3A). Accordingly, the ceramic powder is preferably modified for an increased Ca-content in 30 aluminate (the C 3 A-CA-system). If using C3A or some other phase that is rich in calcium, more calcium is obtained that can react with phosphorous to P OPER\NJL\l2546710 am.d doc-26/0/2009 -8 form apatite. In addition, C3A hardens fast which is good in a thin layer that is to be applied onto the tooth/bone before the filling takes place. f. The material may comprise carbonate or biologically existing ions that may form: oxalates, lactates, calcite, aragonite citrate. Carbonate ions may for 5 example form calcite and calcium may form difficultly soluble biological salts with the anion of the lactic acid, lactate etc. Effect: by controlling the concentration and the composition of the ions, different biological phases containing Ca may be deposited. This also applies to water-soluble additives in the powder raw material. 10 g. The addition of water-soluble phosphate may be achieved by addition of a phase that forms phosphate ions during hydration (P 2 0 5 , active glass containing phosphorous, bioglass, Apatite-Wollastonite glass e.g.). Additives of elements that deliver phosphate in water, such as tricalcium phosphate, alkali salts, are also included in the concept of "addition of 15 water-soluble phosphate". h. It is also possible to supply phosphorous by pre-coating particles (filler or cement) with phosphate or phosphorous. Such a pre-coating may easily be performed by dissolving crystals of phosphoric acid e.g. in an inert solvent, isopropanol e.g. Fillers and cement particles are then mixed in the 20 isopropanol, where after the isopropanol is driven off and phosphate/phosphorous remains on the particles. i. It is also possible to form solid solutions of cement phase (calcium silicates or calcium aluminates) and phosphorous, according to the principles described in SE-AO-0103189-7. The concentration of phosphorous that is 25 possible to dissolve in the cement is < 10 % by atoms, preferably < 5 % by atoms. j. Also other apatites than hydroxyapatite and that function well in the body, can be included in the concept of "apatite" and may in the present text also be included in the concept of "hydroxyapatite", chloride-apatite, carbonate 30 apatite, fluoride-apatite and magnesium apatite e.g. Chloride-apatite may easily be formed by dissolving chloride in the hydration liquid or P:NOPER\NIL\I2546710amend doc-26/03/2009 -9 alternatively by incorporating a readily soluble salt in the material. Carbonate apatite may be formed by hydrating in carbonated phosphoric acid. Fluoride-apatite may be formed by addition of fluoride, in the form of LiF e.g. as an accelerator and magnesium apatite may be formed by 5 precipitation reaction at the forming of apatite with Mg in the aqueous solution. k. For dental filling or implant materials, the powdered material may take the form of a raw compact that preferably exhibits a degree of compaction of at least 55 % by volume solid phase, more preferred at least 60 % by volume 10 solid phase, even more preferred at least 65 % by volume solid phase and most preferred of all at least 70 % by volume solid phase. 1. As an alternative, the powdered material may exist in loose powder form, in which case it is mixed with the hydration liquid to form a suspension that is subsequently drained and compacted. 15 The main binder phase of the cement system consists of calcium aluminate (Ca-aluminate), since: 1. Ca-aluminates will give a basic local environment for the apatite, which makes that phase stable (no dissolution, preventing formation of plaque and 20 lactic acid). 2. Ca-aluminate exists in surplus and is formed in all pores in the material contributes to fill the material - if only apatite was used, too little water would be transformed in order for water-filled porosity to be filled by hydrate. 25 3. Ca-aluminate is deposited by acid-base reaction, in which water reacts with the powdered material, that starts to dissolve. In the solution, all constituents exist that are needed for the formation of both calcium aluminate hydrate, gibbsite and apatite (if some type of phosphorous is supplied) and possibly some other biologically favourable phase (calcite, 30 aragonite, lactate etc.). When the solubility product of each substance is reached, a deposition starts to take place. The deposition takes place P OPER\NiL\I2546710 amenddoc-26/03/2009 -10 everywhere, including inside the micro-spaces between the filling material and the tooth wall. Small crystals are deposited in the surface topography in the tooth wall or some other biological contact surface and contributes to the complete disappearance of the contact zone of filling material 5 tooth/bone, leading to micro-structural integration. No gap can be discovered in magnifications of up to 20,000 times. Concludingly: Ca-aluminate is advantageous at presence of apatite, in order to a. Protect the apatite from chemical dissolution at a low pH, 10 b. Ensure that a dense product exists/is formed. (The pump in the system is Ca ions, aluminate ions and OH ions). Additionally added ions such as phosphates, fluorides, carbonates etc. will give a secondary, complementing, purely biological phase, c. Contribute to the formation of a completely tight contact zone (micro 15 structural integration). The hydration liquid The hydration liquid consists of an aqueous liquid that comprises water soluble phosphate or a phase that has the capacity to form water soluble phosphate, whereby the cement 20 system exhibits the capacity during hydration to form apatite. In addition: a) Said water soluble phosphate forms phosphate ions in the liquid, preferably P04', HPO 4 2 , H 2
PO
4 -or some other phosphorous-containing ion such as 25 hydro ammonium phosphate. b) The liquid may also be a bonding liquid, that is applied on bone or tooth before the dental filling material/implant material with additional (free from phosphate or phosphate-containing) hydration liquid is applied, in which case water soluble phosphate in the bonding liquid forms apatite with the 30 dental filling material/implant material.
P:OPER\N[l2546710 am ddoc-26103/2009 - 11 c) The liquid may comprise carbonate or biologically existing ions that may form: oxalates, lactates, calcite, aragonite. Carbonate ions may for example form calcite and calcium may form difficultly soluble biological salts with the anion of the lactic acid, lactate etc. 5 Effect: by controlling the concentration and the composition of the ions, different biological phases 'containing Ca may be deposited. d) The concentration of phosphate ions should be 0.01-5 M, preferably 0.1-2 M and most preferred 0.5-1.5 M. Specifically for the bonding system, the preferred concentrations are even higher, namely 0.01-5 M, preferably 0.5-4 10 M, most preferred 1-3 M. Suitably, phosphate ions exist in concentrations close to saturation in the bonding liquid or the liquid for the bonding system. By using very high concentrations, an increased deposition of apatite may be obtained in the zone between the tooth/bone and the material. 15 Effect: A high concentration will give more apatite phase. e) The pH should be adjusted to at least 7, preferably 7-12.5 and even more preferred 7-11, Effect: The pH controls the equilibrium for deposition of apatite and katoite (main phase in the Ca-aluminate-hydrate system). 20 f) The liquid may comprise added fluoride ions, to a concentration of fluoride ions in the range of 0.01-5 M, preferably 0.1-2 M, most preferred 0.5-1 M, Effect: gives a formation of fluoride-apatite, together with katoite. (Fluoride-apatite is even more stable than hydroxyapatite). g) The liquid may comprise a suspended or emulsified, non hydrated or 25 partially hydrated calcium aluminate cement, for the formation of a basic environment for the apatite. h) The liquid may comprise accelerator and/or superplasticizer. i) Chloride-apatite may be formed by dissolving chlorine in the hydration liquid. Carbonate apatite may be formed by hydrating in carbonated 30 phosphoric acid. Fluoride-apatite may be formed by addition of fluoride, in the form of LiF e.g. as an accelerator and magnesium apatite may be formed P:PER\NILI2546710 ameddoc-26/03/2009 - 12 by precipitation reaction at the forming of apatite with Mg in the aqueous solution. j) The liquid may comprise carbonate or biologically existing ions that have the capacity to form one or more of calcite aragonite, oxalates, lactates, 5 citrates. The application method for bonding systems Before the bonding system is applied on the tooth wall/the bone, the tooth wall/the bone can be prepared by so called coarsening technique, that normally is performed by etching 10 and/or mechanical coarsening techniques, e.g. micro-blasting. Different suitable, highly concentrated etching agents can be used, but most preferably phosphate-containing etching agents are used, preferably an etching agent in the group that consists of phosphoric acid, hydrophosphoric acid, phosphate buffer and citrates, that will give remaining phosphate substances on the surface that is being treated. After the coarsening, the hydration liquid 15 and the powdered material for the bonding system are mixed and the bonding system thus formed is applied as a thin layer on the tooth/bone, preferably by spraying or painting. Thereafter, the tooth is ready to be filled by the dental filling material or the implant material to be applied/attached to the bone. 20 It is however also conceivable, instead of a bonding system according to what has just been described, or in combination therewith, to prepare the tooth wall/bone (e.g. by spraying or painting) with a bonding liquid which in that case constitutes one embodiment of a hydration liquid according to the invention and that also may constitute an etching agent. Such a bonding liquid/hydration liquid may accordingly exhibit the features 25 described above in connection with the hydration liquid and may solely supply the system with enough water soluble phosphate for a strongly enhanced bonding. Of course, additional phosphate for the formation or apatite may be supplied via the dental filling material/implant material/bonding material, if desired. It should also be understood that such a bonding liquid may be allowed completely or partially to dry up, in which case its 30 dissolved contents (comprising phosphate substances) completely or partially will deposit on the tooth/bone, in order then to be re-dissolved as the dental filling material/implant P:AER\NJLl2546710 amcnd doc.26/03/2009 - 13 material with additional (free from phosphate or phosphate-containing) hydration liquid is applied thereupon. The dentalfilling or implant material in connection with bonding systems 5 It is preferred for an extra good bonding to the tooth/bone, that the dental filling material/implant material consists of a chemically bonded ceramic material that is compatible with the bonding system. Accordingly, it is preferred that also the dental filling material/implant material comprises a powdered material, the binder phase of which essentially consisting of a calcium based cement system, which powdered material has the 10 capacity following saturation with a hydration liquid reacting with the binder phase to hydrate to a chemically bonded ceramic material, said powdered material and/or said hydration liquid comprising water soluble phosphate or a phase that has the capacity to form water soluble phosphate, whereby the dental filling material/implant material exhibits the capacity during and/or after hydration to form apatite. Hereby, an excellent integration 15 and bonding is achieved between the actual bonding system and the dental filling material/implant material. It should be understood that also other aspects that have been described here for the bonding system, can be applicable for the dental filling material/implant material. However, the dental filling material/implant material is suitably adapted for the formation of a lower content of apatite, 0.01-30 % by volume apatite 20 preferably being formed in the cement system during the hydration. DESCRIPTION OF DRAWINGS In the following, embodiments of the invention, including the mechanism at implanting will be described in greater detail by way of example only. A photograph of micro 25 structural integration when using a bonding system according to an embodiment of the invention, is also shown. Fig. 1 shows an outer part of an implant with a coating, as seen in cross-section, Fig. 2 shows the part according to Fig. 1, provided with an extra, outermost layer, as seen 30 in cross-section, POPER\NJL\12546710 amwd doc.26/03/2009 -14 Fig. 3 shows the part according to Fig. 2 immediately after it has been implanted against a biological wall, as seen in cross-section, Fig. 4 show the system according to Fig. 3, after about one hour, Fig. 5 shows the system according to Fig. 3-4 after healing, 5 Fig. 6 shows a photograph in 20,000 times magnification, of the transition area between a tooth wall and a dental filling material, in which transition area a bonding system according to an embodiment of the invention has been applied. In the figures, detail no. 1 symbolises an implant with a metal, ceramic or polymeric 10 substrate. Fig. 1 shows how a coating layer 2 of CAH-HAP has been applied and hydrated. Fig. 2 shows how an extra, outermost layer 3 has been applied on the coating 2, just before the implantation is to begin. The coating layer 2 suitably exhibits a thickness of 0.5-20 pm, preferably less than 10 pm, and even more preferred 0.5-3 pm. The outer layer 3 suitably exhibits a thickness of 0.5-10 pm, preferably less than 5 pm, and even more preferred 0.5 15 3 pm. The outer layer 3 is composed of non-reacted CA (without any hydration liquid) that comprises phosphate. The size of the crystals in the phases in layer 2 and/or 3 is 5 pm at the most, preferably less than 1 ym. Fig. 3 shows how the implant 1 with the coating layer 2 and the outer layer 3 has been 20 implanted against a biological wall in existing hard tissue, usually bone tissue 4, of the patient. Immediately after the implantation, there is a gap x of 10 pm magnitude between the outer surface of the implant and the hard tissue, which gap always will arise even if the implant is put completely in abutment with the hard tissue. 25 Fig. 4 shows how the gap, after about one hour, has shrunk to a gap x' of about 7 pm. This depends on the outer, non-reacted layer 3 having hydrated to a hydrated layer 3', in which case 1-3 pm surface growth normally has occurred by chemical mass growth on the outer layer 3, 3'. This mass growth depends on an uptake of water, body fluid or hydration liquid, in the non-reacted layer 3. 30 P:OPER\NJL%12546710 amaid doc-26/03/2009 - 15 Fig. 5 shows how the implant I has been integrated with the hard tissue 4, after healing 4'. The healing and integration will be extra fast, since Ca-ions and phosphate/apatite are supplied to the area via the coating 2 and the outer layer 3. The biologically induced growth of new bone tissue 4' is united with the outer grown layer 3'. The biologically 5 related growth is positively affected by the presence of HAP. The size of the gap has, according to the above, been diminished by the chemical growth of layer 3', which per se will accelerate the biological filling of new bone tissue 4' in the gap. Fig. 6 shows a photograph in 20,000 times magnification, of the transition area between a 10 tooth wall and a dental filling material, in which transition area a bonding system according to the invention has been applied. The photograph shows a formation of a tight union between filling and tooth wall by deposition/application of a chemically bonded ceramic composite in the bonding system. This depositing takes place everywhere internally in the pore system of the bonding system but also in micro-spaces between the 15 filling material and the tooth wall. Small crystals are deposited in the surface topography and will, by micro-structural integration, contribute to the complete disappearance of the contact zone between filling material-tooth. The invention is not limited by the preferred embodiments but may be varied within the 20 scope of the claims. In particular, it should be realised that other aspects of the system/powdered material/hydration liquid may follow what is taught in SE 463,493, SE 502,987, WO 00/21489, WO 01/76534, WO 01/76535, SE-AO-0103189-7 or SE-AO 0103190-5, which aspects hereby are incorporated by reference. It should also be understood that the powdered material and the hydration liquid, respectively, may be used 25 in combination but also separately and in that case together with conventional hydration liquids and powdered materials, as for example those described in the just mentioned older patent applications. Throughout this specification and the claims which follow, unless the context requires 30 otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps P:OPER\NL l254710amcddc-2&03/209 -16 but not the exclusion of any other integer or step or group of integers or steps. The reference in this specification to any prior publication (or information derived from it), or to any matter which is known, is not, and should not be taken as an acknowledgment or 5 admission or any form of suggestion that that prior publication (or information derived from it) or known matter forms part of the common general knowledge in the field of endeavour to which this specification relates.

Claims (42)

1. A system for a dental filling material or an implant material, alternatively a system for bonding between a tooth or a bone and a dental filling material and a implant material 5 respectively, which system comprises a water based hydration liquid and a powdered material, the powdered material comprising a binder phase consisting essentially of a calcium aluminate based cement system, the powdered material having the capacity following saturation with the hydration liquid of reacting to form a chemically bonded ceramic material, wherein said powdered material and/or said hydration liquid comprises 10 water soluble phosphate or a phase that has the capacity to form water soluble phosphate so that apatite is formed during and/or after hydration of said powdered material.
2. A system according to claim 1, having the capacity to form 0.01 to 30 % by volume apatite during and/or after hydration. 15
3. A system for bonding between a tooth or a bone and a dental filling material and a implant material respectively according to claim 1, having the capacity to form 0.01 to 60 % by volume apatite during and/or after hydration. 20
4. A system according to any one of the preceding claims, having a pH of at least 7.
5. A system according to any one of the preceding claims, wherein the binder phase consists essentially of fine grain 3CaO-Al 2 0 3 having a mean particle size of at most 5 sm and the hydration liquid comprises phosphoric acid with tricalcium phosphate. 25
6. A system for a dental filling material or an implant material, alternatively a bonding system for bonding between a tooth or a bone and a dental filling material and a implant material respectively, substantially as hereinbefore described with reference to the drawings. 30 P:OPER\JflM 2546710 ammddoc-26/03/2009 - 18
7. A powdered material for use in a system according to any one of claims 1 to 6, said powdered material comprising a binder phase consisting essentially of a calcium aluminate based cement system, the powdered material having the capacity following saturation with a hydration liquid of reacting to form a chemically bonded ceramic material, wherein the 5 powdered material comprises water soluble phosphate or a phase that has the capacity to form water soluble phosphate so that apatite is formed during and/or after hydration of said powdered material.
8. A powdered material according to claim 6, wherein said water soluble phosphate is 10 an alkali phosphate.
9. A powdered material according to claim 7 or 8, further comprising grains of a phosphate-containing phase. 15
10. A powdered material according to any one of claims 7 to 9, further comprising high-molecular proteins.
11. A powdered material according to any one of claims 7 to 10, further comprising from 0.5% and up to 10% of a fluoride-containing phase of non difficultly soluble 20 character.
12. A powdered material according to any one of claims 7 to 11, further comprising carbonate or biologically existing ions that have the capacity to form one or more of calcite aragonite, oxalates, lactates, citrates. 25
13. A powdered material according to any one of claims 7 to 12, wherein the phosphate or phosphate-forming phase exists as particles that are precoated by a material comprising phosphate or phosphate-containing phase. P OPIRERNL2546710a=mcddoc.26/032009 - 19
14. A powdered material according to any one of claims 7 to 13, wherein the phosphate or phosphate-forming phase exists by the cement system comprising phosphate-containing phase in solid solution in the cement system. 5
15. A powdered material according to any one of claims 7 to 14, wherein the cement system is a bonding system that has the capacity during and/or after saturation with the hydration liquid to form 0.01% to 60 % by volume apatite.
16. A powdered material according to any one of claims 7 to 15, wherein the cement 10 system is a bonding system that has a larger mole content of calcium than of aluminium.
17. A powdered material according to any one of claims 7 to 16, wherein the cement system has the capacity during and/or after saturation with the hydration liquid to form 0.01% to 30 % by volume apatite. 15
18. A powdered material according to any one of claims 7 to 17, existing as a raw compact having a degree of compaction of at least 55 % by volume solid phase.
19. A powdered material, substantially as hereinbefore described with reference to the 20 drawings.
20. An aqueous hydration liquid for use in a system according to any one of claims 1 to 6, said aqueous hydration liquid for hydrating a powdered material having a binder phase that consists essentially of a calcium aluminate based cement system, said powdered 25 material having the capacity following saturation with the hydration liquid of reacting to hydrate to a chemically bonded ceramic material, wherein the hydration liquid comprises water soluble phosphate or a phase that has the capacity to form water soluble phosphate, so that apatite is formed during and/or after hydration of said powdered material. 30
21. A hydration liquid according to claim 20, wherein said water soluble phosphate exists or has the capacity to be formed in an amount of at least 0.01 to 5 M. P')PER\NJL\12546710 .madoc.26/03/2009 - 20
22. A hydration liquid according to claim 20 or 21, wherein said water soluble phosphate comprises phosphate ions in the group that consists of P0'~, HP02-, H 2 P0 4 , hydro-ammonium phosphate and other phosphorous-containing ions. 5
23. A hydration liquid according to any one of claims 20 to 22, having a pH of at least 7.
24. A hydration liquid according to any one of claims 20 to 23, further comprising 10 suspended or emulsified, non hydrated or partially hydrated calcium aluminate cement for the formation of a basic environment for the apatite.
25. A hydration liquid according to any one of claims 20 to 24, further comprising carbonate or biologically existing ions that have the capacity to form one or more of calcite 15 aragonite, oxalates, lactates, citrates.
26. A hydration liquid according to any one of claims 20 to 25, further comprising fluoride ions in a concentration of 0.01-5 M. 20
27. A hydration liquid according to any one of claims 20 to 26, further comprising an accelerator and/or a superplasticizer.
28. A hydration liquid, substantially as hereinbefore described with reference to the drawings. 25
29. A hydration liquid according to any one of claims 20 to 28, for use in the bonding system according to any one of claims I to 6.
30. An implant material comprising a substrate, wherein said substrate comprises a 30 hydrated coating layer formed from a system according to any one of claims 1 to 6. P'0PER\NJLI 2546710 amwd doc26d03/209 - 21
31. An implant material according to claim 30, wherein the hydrated coating layer has a thickness of 0.5 to 20 pm.
32. An implant material according to claim 30 or 31, wherein the hydrated coating 5 layer comprises an outer layer of a powdered material on top of it and said powdered material comprises water soluble phosphate or a phase that has the capacity to form water soluble phosphate.
33. An implant material according to claim 32, wherein the outer layer has a thickness 10 of 0.5 to 10 pm.
34. An implant material according to any one of claims 30 to 33, wherein a crystal size in the hydrated coating layer is 5 pm at the most. 15
35. An implant material substantially as hereinbefore described with reference to the drawings.
36. A method of achieving bonding between a tooth or a bone and a dental filling material and an implant material respectively, the method comprising using the system for 20 bonding according to any one of claims I to 6.
37. A method according to claim 36, wherein a powdered material according to any one of claims 7 to 19 and/or a hydration liquid according to any one of claims 20 to 28, is used in the bonding system. 25
38. A method according to claim 36 or 37, wherein the tooth or bone is pre-treated by etching with an etching agent and/or by mechanical coarsening techniques.
39. A method according to claim 38, wherein said etching agent comprises a 30 phosphate-containing etching agent selected from the group that consists of phosphoric acid, hydrophosphoric acid, phosphate buffer and citrates. P:QPER\NJL112546710 awmddoc-2&3/209 - 22
40. A method according to any one of claims 36 to 39, wherein the bonding system is applied onto the tooth or bone by painting or spraying, followed by application of said dental filling/implant material onto said bonding system. 5
41. A method according to claim 40, wherein said dental filling/implant material is chosen to be compatible with the bonding system, said dental filling/implant material formed from a system in accordance with any one of claims 1 to 6. 10
42. A method of achieving bonding between a tooth or a bone and a dental filling material and an implant material respectively, substantially as hereinbefore described with reference to the drawings.
AU2003238999A 2002-06-20 2003-06-11 System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding Ceased AU2003238999B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE0201921-4 2002-06-20
SE0201920A SE522511C2 (en) 2002-06-20 2002-06-20 System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase
SE0201920-6 2002-06-20
SE0201921A SE522510C2 (en) 2002-06-20 2002-06-20 System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase
SE0202998-1 2002-10-09
SE0202998A SE0202998D0 (en) 2002-10-09 2002-10-09 Dental fill or implant material system
PCT/SE2003/000954 WO2004000239A1 (en) 2002-06-20 2003-06-11 System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding

Publications (2)

Publication Number Publication Date
AU2003238999A1 AU2003238999A1 (en) 2004-01-06
AU2003238999B2 true AU2003238999B2 (en) 2009-05-07

Family

ID=30003625

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003238999A Ceased AU2003238999B2 (en) 2002-06-20 2003-06-11 System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding

Country Status (8)

Country Link
US (1) US7699925B2 (en)
EP (1) EP1534212A1 (en)
JP (1) JP2005537832A (en)
CN (1) CN1290483C (en)
AU (1) AU2003238999B2 (en)
BR (1) BR0311971A (en)
CA (1) CA2489823A1 (en)
WO (1) WO2004000239A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE525236C2 (en) 2002-10-31 2005-01-11 Cerbio Tech Ab Process for making structured ceramic coatings and coated devices made with this process
SE526985C2 (en) * 2003-11-27 2005-11-29 Doxa Ab Fixation system for implant elements
SE528360C2 (en) * 2004-09-10 2006-10-24 Doxa Ab Resorbable ceramic compositions intended for medical implants
CN101124178B (en) * 2005-03-25 2010-11-10 创新生物陶瓷公司 Hydraulic cement compositions and methods of making and using the same
US20130236517A1 (en) * 2010-11-16 2013-09-12 Doxa Ab Apatite Forming Biomaterial
CN102276223B (en) * 2011-06-03 2013-07-17 河南中隆科技有限责任公司 Novel flexible wear-resistant ceramic coating and preparation method thereof
CN102961259A (en) * 2012-12-12 2013-03-13 郑荣荣 Hard coating material used for dental restoration and preparation method thereof
WO2016005822A1 (en) 2014-07-07 2016-01-14 Aduro Material Ab Cement systems, hardened cements and implants
CN104906635B (en) * 2015-06-19 2017-05-31 四川大学 A kind of polyether-ether-ketone/nanometer hydroxyapatite tooth implant and preparation method thereof
US20210401543A1 (en) * 2017-11-06 2021-12-30 3M Innovative Properties Company Dental crown having a highly retentive coating and method for making the same
JP7186628B2 (en) * 2019-01-29 2022-12-09 太平洋セメント株式会社 Cement composition for bone or tooth repair
CN110974462B (en) * 2019-12-09 2022-03-01 深圳光韵达光电科技股份有限公司 Method for manufacturing teeth based on mold

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33221A (en) * 1861-09-03 Improvement in soap
US4959104A (en) * 1985-10-11 1990-09-25 Mitsui Toatsu Chemicals, Inc. Self-hardenable material
US5342441A (en) * 1991-06-26 1994-08-30 Nitta Gelatin Inc. Biologically compatible hardening material for dental or medical applications
US5525148A (en) * 1993-09-24 1996-06-11 American Dental Association Health Foundation Self-setting calcium phosphate cements and methods for preparing and using them
WO2000021489A1 (en) * 1998-10-12 2000-04-20 Doxa Certex Aktiebolag Dimension stable binding agent systems
US6143069A (en) * 1997-08-15 2000-11-07 Halliburton Energy Services, Inc. Light weight high temperature well cement compositions and methods
WO2001076535A1 (en) * 2000-04-11 2001-10-18 Doxa Aktiebolag Chemically bound ceramic product, method for its production, tool to be used in execution of the method and interchangeable part on the tool
WO2001076534A1 (en) * 2000-04-11 2001-10-18 Doxa Aktiebolag Method for producing a chemically bound ceramic product, and product

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1450157A (en) * 1973-03-06 1976-09-22 Colgate Palmolive Co Dental powder cement and filling material
US4518430A (en) * 1982-04-29 1985-05-21 American Dental Association Health Foundation Dental resptorative cement pastes
USRE33221E (en) * 1982-04-29 1990-05-22 American Dental Association Health Foundation Dental restorative cement pastes
JPS59111753A (en) * 1982-12-15 1984-06-28 住友電気工業株式会社 Artificial medical material and use thereof
JPS59214443A (en) * 1983-05-20 1984-12-04 ミノルタ株式会社 Artificial implant material
JPS61229806A (en) * 1985-04-05 1986-10-14 G C Dental Ind Corp Dental aluminic acid cement composition
JP2604135B2 (en) 1986-02-28 1997-04-30 ライオン株式会社 Oral bone disease treatment
ATE134136T1 (en) * 1989-10-20 1996-02-15 Bioapatite Ab IMPLANT MATERIAL COMPOSITION, THEIR PRODUCTION AND THEIR USES AND THE IMPLANT OBTAINED THEREFROM
US5281265A (en) * 1992-02-03 1994-01-25 Liu Sung Tsuen Resorbable surgical cements
FR2693716B1 (en) * 1992-07-20 1994-10-21 Toulouse Inst Nat Polytech Process for obtaining phosphocalcic hydroxyapatite, applications for bone or dental filling, or molding of parts, and products used.
DE4303575C1 (en) * 1993-02-08 1994-04-14 Electro Chem Eng Gmbh Prodn of apatite-coated metal implants - using soln of alkali or alkaline earth metal salts contg hydroxy:apatite and/or fluoro:apatite
JPH07194686A (en) * 1994-01-10 1995-08-01 Pola Chem Ind Inc Biomedical cement
SE504523C2 (en) 1995-06-19 1997-02-24 Ericsson Telefon Ab L M Device and method for linking customers to servers during runtime in a distributed telecommunications network
DE19529223A1 (en) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Use of plasminogen activators for local bone building
SE513556C2 (en) * 1997-11-11 2000-10-02 Nobel Biocare Ab Implant element with thin surface applied by hot isostatic pressing
US6139585A (en) * 1998-03-11 2000-10-31 Depuy Orthopaedics, Inc. Bioactive ceramic coating and method
FR2776282B1 (en) * 1998-03-20 2000-05-19 Toulouse Inst Nat Polytech PROCESS FOR THE PREPARATION OF A HYDROXYAPATITE-BASED BIOMATERIAL, BIOMATERIAL OBTAINED AND SURGICAL OR DENTAL APPLICATION
US6558709B2 (en) * 2001-01-05 2003-05-06 Howmedica Osteonics Corp. Calcium phosphate composition and method of preparing same
SE521938C2 (en) * 2001-12-27 2003-12-23 Cerbio Tech Ab Ceramic material, process for making ceramic material and bone implants, dental filling implants and bio cement comprising the ceramic material
EP1476204B1 (en) * 2002-02-21 2008-10-08 Encelle, Inc. Immobilized bioactive hydrogel matrices as surface coatings

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33221A (en) * 1861-09-03 Improvement in soap
US4959104A (en) * 1985-10-11 1990-09-25 Mitsui Toatsu Chemicals, Inc. Self-hardenable material
US5342441A (en) * 1991-06-26 1994-08-30 Nitta Gelatin Inc. Biologically compatible hardening material for dental or medical applications
US5525148A (en) * 1993-09-24 1996-06-11 American Dental Association Health Foundation Self-setting calcium phosphate cements and methods for preparing and using them
US6143069A (en) * 1997-08-15 2000-11-07 Halliburton Energy Services, Inc. Light weight high temperature well cement compositions and methods
WO2000021489A1 (en) * 1998-10-12 2000-04-20 Doxa Certex Aktiebolag Dimension stable binding agent systems
WO2001076535A1 (en) * 2000-04-11 2001-10-18 Doxa Aktiebolag Chemically bound ceramic product, method for its production, tool to be used in execution of the method and interchangeable part on the tool
WO2001076534A1 (en) * 2000-04-11 2001-10-18 Doxa Aktiebolag Method for producing a chemically bound ceramic product, and product

Also Published As

Publication number Publication date
JP2005537832A (en) 2005-12-15
BR0311971A (en) 2005-03-22
CN1662208A (en) 2005-08-31
US20060086287A1 (en) 2006-04-27
AU2003238999A1 (en) 2004-01-06
CN1290483C (en) 2006-12-20
EP1534212A1 (en) 2005-06-01
WO2004000239A1 (en) 2003-12-31
US7699925B2 (en) 2010-04-20
CA2489823A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
US6224635B1 (en) Implantation of surgical implants with calcium sulfate
AU2003238999B2 (en) System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding
US5149368A (en) Resorbable bioactive calcium phosphate cement
ES2397395T3 (en) Cements of ammonium magnesium phosphate, its preparation and use
EP1123081B1 (en) Hardenable ceramic hydraulic cement
EP0899247B1 (en) Calcium phosphate cement and calcium phosphate cement composition
JP2773752B2 (en) Storage stable formulations for calcium phosphate minerals prepared in situ
US6706273B1 (en) Composition for implantation into the human and animal body
CN100549232C (en) The device for preparing the method for structurizing ceramic coating and prepare thus with coating
US20050287071A1 (en) Formulation for a cement preparation as bone substitute
CN101014376A (en) Resorbable ceramic compositions
EP0347028A2 (en) Calcium phosphate mineral compositions and methods for preparing same
JP2006524058A (en) Formulations for cement preparations as bone substitutes
WO2004058194A1 (en) Chemically bonded biomaterial with tailored properties
US20070173952A1 (en) Implant and method of producing the same, and a system for implantation
JP2006524058A5 (en)
US20200061235A1 (en) Macroporous Granules of Alkaline Earth Phosphates Using Cement Technology and Gas Evolving Porogen
CN1189221C (en) Endosteal planting body for guiding bone tissue into growth and its preparation method
ZA200500277B (en) System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding
RU2332201C2 (en) Composition of dental filling material or implant material, powder material, hydration fluid, implant material and method of cohesion
LeGeros 8. Calcium Phosphate Biomaterials in Preventive and Restorative Dentistry
WO2024133597A1 (en) Bioadhesive composition
JP6140999B2 (en) Bone-binding material, artificial bone, and method for promoting bonding between base material and autologous bone
SE522510C2 (en) System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired